Q32 Bio Inc. (LON: 0T6G)
London
· Delayed Price · Currency is GBP · Price in USD
3.418
+0.026 (0.78%)
Jan 22, 2025, 7:15 PM BST
Q32 Bio Revenue
Q32 Bio had revenue of $-14.66M USD in the twelve months ending September 30, 2024, down -224.35% year-over-year. In the year 2023, Q32 Bio had annual revenue of $-6.65M, down -200.00%.
Revenue (ttm)
$-14.66M
Revenue Growth
-224.35%
P/S Ratio
n/a
Revenue / Employee
$-396.27K
Employees
37
Market Cap
34.02M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | -6.65M | -13.30M | -200.00% |
Dec 31, 2022 | 6.65M | - | - |
Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionQ32 Bio News
- 6 weeks ago - Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
- 6 weeks ago - Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
- 6 weeks ago - Q32 Bio Crashes 67% On A 'Messy' Update In Eczema, Alopecia Treatment - Investor's Business Daily
- 6 weeks ago - Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program - PRNewsWire
- 2 months ago - Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - PRNewsWire
- 3 months ago - Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - PRNewsWire
- 5 months ago - Q32 Bio to Participate in Upcoming September Investor Conferences - PRNewsWire